| Patents for C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465) |
|---|
| 10/29/2013 | US8569322 Lamivudine oxalate and preparation method thereof |
| 10/24/2013 | WO2013156318A1 Substituted pesticidal pyrazole compounds |
| 10/22/2013 | US8563596 Enantiomerically pure compounds for the treatment of proliferative disorders |
| 10/22/2013 | US8563566 Naphthyridine derivatives as potassium channel modulators |
| 10/10/2013 | WO2013151297A1 Novel organic electroluminescent compounds and organic electroluminescent device comprising the same |
| 10/02/2013 | EP2644600A1 Heterocyclic aspartyl protease inhibitors |
| 10/01/2013 | US8546569 Chemical compounds |
| 10/01/2013 | US8546405 Anti-viral compounds |
| 10/01/2013 | US8546401 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases |
| 09/18/2013 | CN1578779B Small organic molecule regulators of cell proliferation |
| 09/18/2013 | CN102167696B Lamivudine oxalate and preparation method thereof |
| 09/17/2013 | US8536340 Cross-linked cyclic amine compounds and agents for pest control |
| 09/17/2013 | US8536182 Benzylpiperazine derivatives and their medical use |
| 09/10/2013 | US8530138 Salt and photoresist composition comprising the same |
| 09/03/2013 | US8524724 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 08/29/2013 | DE102012202782A1 Neue Oxidationsfarbstoffvorprodukte Last oxidation dye precursors |
| 08/28/2013 | CN103265477A Aminoheteroaryl compounds as protein kinase inhibitors |
| 08/21/2013 | CN101522674B Novel compounds, pharmaceutically acceptable salts as vanilloid receptor antagonist and pharmaceutical composition comprising the compounds |
| 08/20/2013 | US8513406 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 08/15/2013 | WO2013117649A1 Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases |
| 08/15/2013 | WO2013117645A1 Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases |
| 08/08/2013 | US20130203747 Inhibitors of human immunodeficiency virus replication |
| 08/06/2013 | US8501777 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission |
| 08/06/2013 | US8501773 4-fluoro-piperidine T-type calcium channel antagonists |
| 07/16/2013 | US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders |
| 07/09/2013 | US8481554 Solid oral dosage forms of lamivudine |
| 07/02/2013 | US8476295 Bridged bicyclic RHO kinase inhibitor compounds, composition and use |
| 06/26/2013 | EP2606727A1 Compounds with nematicidal activity |
| 06/25/2013 | US8471014 Process of making gyrase and topoisomerase IV inhibitors |
| 06/11/2013 | CA2722102C Phenylpropionic acid derivative and use thereof |
| 06/05/2013 | CN101142211B Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof |
| 05/28/2013 | US8450341 Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors |
| 05/23/2013 | US20130131034 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 05/22/2013 | EP2594565A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/22/2013 | EP2594564A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/22/2013 | EP2594563A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/22/2013 | EP2594562A2 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| 05/21/2013 | US8445684 Nicotinic acetylcholine receptor ligands and the uses thereof |
| 05/21/2013 | US8445683 Porphyrin compounds comprising one or more pyridone moieties |
| 05/14/2013 | US8440639 Combination compositions for reducing intraocular pressure |
| 05/10/2013 | WO2013064461A2 Compounds with nematicidal activity |
| 05/09/2013 | US20130116231 Tyrosine kinase inhibitors |
| 05/08/2013 | EP2588451A1 Piperidine derivatives and their use for the treatment of metabolic disorders |
| 05/01/2013 | CN103080087A Piperidine derivatives and their use for the treatment of metabolic disorders |
| 04/30/2013 | US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 04/30/2013 | CA2517256C Aminoheteroaryl compounds as protein kinase inhibitors |
| 04/25/2013 | US20130102468 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides |
| 04/24/2013 | CN101993439B Lamivudine crystal form and preparation method thereof |
| 04/23/2013 | US8426424 Certain substituted amides, method of making, and method of use thereof |
| 04/16/2013 | US8420661 Arylethynyl derivatives |
| 04/10/2013 | CN101903353B Aminopyrazole derivatives |
| 04/09/2013 | US8415378 Isoxazol-3(2H)-one analogs as therapeutic agents |
| 04/03/2013 | CN103012386A Preparation method of five-membered cyclic sulphate |
| 03/28/2013 | WO2013016193A3 Activators of class i histone deacetlyases (hdacs) and uses thereof |
| 03/21/2013 | US20130072681 Process for stereoselective synthesis of 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine |
| 03/20/2013 | CN102977028A Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives |
| 03/19/2013 | US8399683 IAP inhibitors |
| 03/19/2013 | US8399655 Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1′-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof |
| 03/13/2013 | EP2566477A1 Amino-quinolines as kinase inhibitors |
| 03/13/2013 | CN101805334B Lamivudin stearate and synthesis method and application |
| 03/07/2013 | WO2013032591A1 Heterocyclic compounds and uses thereof |
| 03/07/2013 | US20130059838 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059810 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 03/07/2013 | US20130059809 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 03/07/2013 | CA2846431A1 Heterocyclic compounds and uses thereof |
| 03/06/2013 | EP2563143A1 Substituted 1,3-benzothiazol-2(3h)-ones and [1,3]thiazolo[5,4-b]pyridin-2(1h)-ones as positive allosteric modulators of mglur2 |
| 03/06/2013 | CN102952112A Tricyclic guanidine derivatives as sodium-proton exchange inhibitors |
| 02/28/2013 | WO2013027168A1 Novel heterocyclic compounds as bromodomain inhibitors |
| 02/28/2013 | US20130053560 Lamivudine oxalate and preparation method thereof |
| 02/28/2013 | US20130053375 Amino-quinolines as kinase inhibitors |
| 02/27/2013 | CN102942563A Polymorphic and other crystalline forms of cis-ftc |
| 02/19/2013 | US8378123 Composition, synthesis, and use of new substituted pyran and pterin compounds |
| 02/19/2013 | US8377983 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
| 02/14/2013 | WO2013021290A1 A stereoselective process for preparation of 1,3-oxathiolane nucleosides |
| 02/12/2013 | US8372880 Compositions and methods using same for treating amyloid-associated diseases |
| 02/06/2013 | CN102911167A Method for preparing nucleoside intermediate with high optical purity |
| 02/06/2013 | CN102911166A Polymorphic And Other Crystalline Forms of Cis-FTC |
| 02/06/2013 | CN102911165A Polymorphic and other crystalline forms of cis-FTC |
| 02/05/2013 | CA2714085C Method of manufacture of 1,3-oxathiolane nucleosides |
| 01/31/2013 | WO2013016193A2 Activators of class i histone deacetlyases (hdacs) and uses thereof |
| 01/31/2013 | CA2842524A1 Activators of class i histone deacetlyases (hdacs) and uses thereof |
| 01/24/2013 | US20130023527 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 01/09/2013 | EP2542551A1 A process for stereoselective synthesis of 5-fluoro-1-(2r,5s)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine |
| 01/08/2013 | US8350055 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 01/08/2013 | US8350030 Process for producing 5-fluoro-1-(2R, 5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine |
| 01/08/2013 | US8349859 Pyrimidine derivatives |
| 01/02/2013 | EP2540717A1 Lamivudine oxalate and preparation method thereof |
| 01/02/2013 | CN1995022B Process for the synthesis of nucleoside analogues |
| 01/02/2013 | CN101765589B Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives |
| 12/27/2012 | WO2011083484A3 Improved process for nucleosides |
| 12/13/2012 | US20120316339 Preparation of Lamivudine Form I |
| 12/04/2012 | US8324133 Fungicide 2-pyridyl-methylene-carboxamide derivatives |
| 11/28/2012 | CN102803255A Novel GPR 119 agonists |
| 11/28/2012 | CN102796089A Preparation method of lamivudine intermediate and lamivudine |
| 11/28/2012 | CN102796088A Method for preparing lamivudine |
| 11/27/2012 | US8318777 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 11/22/2012 | WO2012155199A1 Amine derivatives as potassium channel blockers |
| 11/22/2012 | US20120295930 Novel process for the preparation of cis-nucleoside derivative |
| 11/22/2012 | CA2836311A1 Amine derivatives as potassium channel blockers |
| 11/21/2012 | EP2524912A1 Amine derivatives |